دورية أكاديمية
IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC).
العنوان: | IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC). |
---|---|
المؤلفون: | Coupe, Nicholas, Pinato, David J. James, Fairchild, Justin P., Pastore, Desa Rae Electa, Innaimo, Steven, Thompson, David, Gileadi, Uzi, Kramer, Robert A., Walters, Ian B., Middleton, Mark R. |
المصدر: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2575-2575, 1p |
قاعدة البيانات: | Supplemental Index |
ResultId |
1 |
---|---|
Header |
edo Supplemental Index 164013565 897 6 Academic Journal academicJournal 896.761413574219 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=164013565&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
|
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC).
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Coupe%2C+Nicholas%22">Coupe, Nicholas</searchLink><br /><searchLink fieldCode="AR" term="%22Pinato%2C+David+J%2E+James%22">Pinato, David J. James</searchLink><br /><searchLink fieldCode="AR" term="%22Fairchild%2C+Justin+P%2E%22">Fairchild, Justin P.</searchLink><br /><searchLink fieldCode="AR" term="%22Pastore%2C+Desa+Rae+Electa%22">Pastore, Desa Rae Electa</searchLink><br /><searchLink fieldCode="AR" term="%22Innaimo%2C+Steven%22">Innaimo, Steven</searchLink><br /><searchLink fieldCode="AR" term="%22Thompson%2C+David%22">Thompson, David</searchLink><br /><searchLink fieldCode="AR" term="%22Gileadi%2C+Uzi%22">Gileadi, Uzi</searchLink><br /><searchLink fieldCode="AR" term="%22Kramer%2C+Robert+A%2E%22">Kramer, Robert A.</searchLink><br /><searchLink fieldCode="AR" term="%22Walters%2C+Ian+B%2E%22">Walters, Ian B.</searchLink><br /><searchLink fieldCode="AR" term="%22Middleton%2C+Mark+R%2E%22">Middleton, Mark R.</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2575-2575, 1p ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1200/JCO.2023.41.16_suppl.2575
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 1
[StartPage] => 2575
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC).
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Coupe, Nicholas
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pinato, David J. James
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Fairchild, Justin P.
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pastore, Desa Rae Electa
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Innaimo, Steven
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Thompson, David
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Gileadi, Uzi
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kramer, Robert A.
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Walters, Ian B.
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Middleton, Mark R.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 02
[M] => 06
[Text] => 2023 Supplement 16
[Type] => published
[Y] => 2023
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 0732183X
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 41
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Journal of Clinical Oncology
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |